Literature DB >> 16303922

Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.

Mario A Economou1, Charlotta All-Ericsson, Vladimir Bykov, Leonard Girnita, Armando Bartolazzi, Olle Larsson, Stefan Seregard.   

Abstract

PURPOSE: Uveal melanoma disseminates preferentially to the liver. The mechanism for this homing is largely unknown, but growth factors synthesized in the liver may be involved. The present study was undertaken to investigate the possible relationship between cell surface receptors for two such growth factors: the c-Met proto-oncogene, which constitutes the receptor for hepatocyte growth factor/scatter factor (HGF/SF), and the insulin-like growth factor 1 receptor (IGF-1R). Their role as a prognostic factor was also clarified.
METHODS: Paraffin-embedded tumor specimens from 132 patients with primary uveal melanoma were analyzed by using well-established specific antibodies against c-Met and IGF-1R. The intercorrelation of receptor expression and association with melanoma-related survival of patients were determined by univariate and multivariate analyses.
RESULTS: Whereas the expression of both IGF-1R and c-Met was significantly associated with melanoma-specific mortality by univariate analysis (P = 0.004 and P = 0.007, respectively) only IGF-1R showed independent prognostic value by multivariate analysis, P = 0.004. The prognostic value of IGF-1R was stronger than such currently used prognostic parameters as tumor cell type and tumor diameter (P = 0.021 and P = 0.026, respectively). The expression patterns of the two growth factors receptors were weakly intercorrelated.
CONCLUSIONS: In conclusion, the data suggest that the receptors for IGF-1 and HGF/SF may play a role in the spread of uveal melanoma and its affinity to the liver. The strong correlation between IGF-1R expression and melanoma-specific mortality points to the use of IGF-1R as a prognostic tool.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303922     DOI: 10.1167/iovs.05-0322

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Delayed systemic recurrence of uveal melanoma.

Authors:  Nathalie A Kolandjian; Caimiao Wei; Sapna P Patel; Jessica L Richard; Tina Dett; Nicholas E Papadopoulos; Agop Y Bedikian
Journal:  Am J Clin Oncol       Date:  2013-10       Impact factor: 2.339

2.  IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.

Authors:  Dawei Song; Sonia Cismas; Caitrin Crudden; Eric Trocme; Claire Worrall; Naida Suleymanova; Tingting Lin; Huiyuan Zheng; Stefan Seregard; Ada Girnita; Leonard Girnita
Journal:  Oncogene       Date:  2021-11-17       Impact factor: 9.867

3.  First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.

Authors:  Aiwu Ruth He; Roger B Cohen; Crystal S Denlinger; Ashwin Sama; Ariel Birnbaum; Jimmy Hwang; Takami Sato; Nancy Lewis; Michelle Mynderse; Michele Niland; Jennifer Giles; Johan Wallin; Brian Moser; Wei Zhang; Richard Walgren; Elizabeth R Plimack
Journal:  Oncologist       Date:  2019-03-04

4.  Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis.

Authors:  Jean-Claude Marshall; Andre Nantel; Paula Blanco; Josee Ash; Stephanie R Cruess; Miguel N Burnier
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

Review 5.  Emerging insights into the molecular pathogenesis of uveal melanoma.

Authors:  Solange Landreville; Olga A Agapova; J William Harbour
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

Review 6.  The biology and management of uveal melanoma.

Authors:  Takami Sato; Fei Han; Akira Yamamoto
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

7.  Single-cell tumor dormancy model of uveal melanoma.

Authors:  Patrick T Logan; Bruno F Fernandes; Sebastian Di Cesare; Jean-Claude A Marshall; Shawn C Maloney; Miguel N Burnier
Journal:  Clin Exp Metastasis       Date:  2008-03-12       Impact factor: 5.150

8.  Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation.

Authors:  Abbas K Samadi; Stephanie M Cohen; Ridhwi Mukerji; Vamsee Chaguturu; Xuan Zhang; Barbara N Timmermann; Mark S Cohen; Erica A Person
Journal:  Tumour Biol       Date:  2012-04-05

9.  Uveal melanoma.

Authors:  Vasilios P Papastefanou; Victoria M L Cohen
Journal:  J Skin Cancer       Date:  2011-06-30

10.  MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.

Authors:  Feng Dong; Dinghua Lou
Journal:  Mol Vis       Date:  2012-03-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.